ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Efficacy of TRT in Correcting Anemia in Men With Hypogonadism
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 268330" data-attributes="member: 13851"><p><strong>Figure 4. Incidence of Anemia in Participants Who Did Not Have Anemia at Baseline</strong></p><p><strong>[ATTACH=full]38610[/ATTACH]</strong></p><p>Frequencies and relative risks of incident anemia in the TRT group relative to placebo and 95% CIs at each visit in men who did not have anemia at baseline are shown by treatment group and time point. The risk ratio of incident anemia in the TRT vs placebo group was estimated by a repeated measure log-binomial regression with fixed effects for treatment, visit,treatment-visit interaction, preexisting cardiovascular disease, and a random per-subject repeated measures effect using an unstructured covariance matrix. The omnibus test P value shown in the figure is a test of the null hypothesis of no difference between TRT and placebo groups across all time points.</p></blockquote><p></p>
[QUOTE="madman, post: 268330, member: 13851"] [B]Figure 4. Incidence of Anemia in Participants Who Did Not Have Anemia at Baseline [ATTACH type="full" alt="Screenshot (30165).png"]38610[/ATTACH][/B] Frequencies and relative risks of incident anemia in the TRT group relative to placebo and 95% CIs at each visit in men who did not have anemia at baseline are shown by treatment group and time point. The risk ratio of incident anemia in the TRT vs placebo group was estimated by a repeated measure log-binomial regression with fixed effects for treatment, visit,treatment-visit interaction, preexisting cardiovascular disease, and a random per-subject repeated measures effect using an unstructured covariance matrix. The omnibus test P value shown in the figure is a test of the null hypothesis of no difference between TRT and placebo groups across all time points. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Efficacy of TRT in Correcting Anemia in Men With Hypogonadism
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top